全文获取类型
收费全文 | 576篇 |
免费 | 42篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 7篇 |
妇产科学 | 8篇 |
基础医学 | 52篇 |
口腔科学 | 2篇 |
临床医学 | 17篇 |
内科学 | 60篇 |
皮肤病学 | 194篇 |
神经病学 | 14篇 |
特种医学 | 17篇 |
外科学 | 28篇 |
综合类 | 4篇 |
预防医学 | 24篇 |
眼科学 | 2篇 |
药学 | 65篇 |
中国医学 | 1篇 |
肿瘤学 | 119篇 |
出版年
2023年 | 3篇 |
2021年 | 4篇 |
2020年 | 12篇 |
2019年 | 10篇 |
2018年 | 13篇 |
2017年 | 13篇 |
2016年 | 16篇 |
2015年 | 12篇 |
2014年 | 16篇 |
2013年 | 19篇 |
2012年 | 32篇 |
2011年 | 26篇 |
2010年 | 18篇 |
2009年 | 13篇 |
2008年 | 25篇 |
2007年 | 24篇 |
2006年 | 30篇 |
2005年 | 20篇 |
2004年 | 30篇 |
2003年 | 24篇 |
2002年 | 15篇 |
2001年 | 20篇 |
2000年 | 36篇 |
1999年 | 14篇 |
1998年 | 9篇 |
1997年 | 8篇 |
1996年 | 10篇 |
1995年 | 8篇 |
1994年 | 7篇 |
1993年 | 3篇 |
1992年 | 8篇 |
1991年 | 18篇 |
1990年 | 13篇 |
1989年 | 16篇 |
1988年 | 5篇 |
1986年 | 7篇 |
1985年 | 3篇 |
1983年 | 3篇 |
1979年 | 2篇 |
1978年 | 4篇 |
1977年 | 4篇 |
1975年 | 5篇 |
1974年 | 6篇 |
1973年 | 2篇 |
1972年 | 3篇 |
1971年 | 10篇 |
1969年 | 4篇 |
1968年 | 2篇 |
1967年 | 5篇 |
1963年 | 2篇 |
排序方式: 共有621条查询结果,搜索用时 15 毫秒
61.
62.
63.
64.
Ulrike LeiterThomas Kurt Eigentler MD Andrea ForschnerAnnette Pflugfelder MD Benjamin WeideLaura Held MD Friedegund MeierClaus Garbe MD 《Clinics in Dermatology》2010
The ongoing increase in melanoma incidence throughout Caucasian populations worldwide raises the question of an economic and efficient management of primary melanoma and follow-up. The primary treatment of a cutaneous melanoma is surgical excision. An excision biopsy is recommended, and safety margins of 1 cm for tumor thickness up to 2 mm and 2 cm for a higher tumor thickness should be applied at the primary excision or in a two-step procedure. When dealing with facial, acral, or anogenital melanomas, micrographic control of the surgical margins may be preferable to allow reduced safety margins and conservation of tissue. Whereas the treatment for primary melanoma is accepted world wide, follow-up strategies for melanoma patients are discussed controversially, and so far, no international consensus has been reached. 相似文献
65.
66.
OBJECTIVES: A re-analysis of data from 51 epidemiological studies reported a significant 14% increase in the risk of breast cancer associated with the use of hormone replacement therapy (HRT). Unlike randomized trials, these observational studies varied in design and methods. This study was conducted to explore the impact of study design factors on the rate ratio. METHODS: We performed a meta-regression analysis of 39 epidemiological studies of HRT and breast cancer. The rate ratio of breast cancer associated with ever use of HRT was evaluated in relation to study design, study period, country, primary study objective, method of exposure measurement, age control, adjustment factors related to reproduction and menopause, and the presence of breast cancer surveillance. We used stepwise multiple regression analysis, weighted by the inverse of the variance of the logarithm of the rate ratio, to estimate ratios of rate ratios for these factors. RESULTS: Exposure measured by personal interview and/or medical record review was associated with a 14% lower rate ratio estimate as compared with telephone interview or self-administered questionnaire (P = 0.018). Among studies that did not adjust for age at menopause, the rate ratio was 12% lower if the primary objective was HRT effect than not (P = 0.016), while it was 43% higher among studies that adjusted for age at menopause (P = 0.042). An index that included as six desirable design features, breast cancer surveillance, matching of controls, more reliable exposure information, adjustment for age at menopause and reproductive risk factors, and as primary objective the effect of HRT suggests that studies with none of these properties would lead to a rate ratio estimate of 1.14 (95% CI: 1.00-1.29) while studies with all six properties would produce a rate ratio of 0.98 (95% CI: 0.83-1.15). CONCLUSIONS: Design factors of epidemiological studies could be an alternative explanation for the reported 14% increase in the risk of breast cancer associated with the use of HRT. 相似文献
67.
68.
Philippe?L.?PereiraEmail author Kristina?Krüger Ernst?Hohenstein Florian?Welke Christof?Sommer Friedegund?Meier Thomas?Eigentler Claus?Garbe 《European radiology》2018,28(4):1456-1464
Objectives
To study feasibility and validity of a new software application for intraprocedural assessment of perfusion during chemoembolisation of melanoma metastases.Methodology
In a prospective phase-II trial, ten melanoma patients with liver-only metastases underwent chemoembolisation with doxorubicin-eluting beads (DEBDOX-TACE). Tumour perfusion was evaluated immediately before and after treatment at cone beam computer tomography (CBCT) using a new software application. For control and comparison, patients underwent perfusion measurement via contrast-enhanced multidetector CT (MDCT) before and after treatment.Results
CBCT showed 94.7 % reduction in perfusion in metastases after DEBDOX-TACE, whereas MDCT showed 96.8 %. Reduction in perfusion after treatment was statistically significant (p < 0.01) for both methods. The additional time needed for data acquisition during treatment was 5 min per case or less; the post-processing data analysis was 10 min or less. Perfusion imaging was associated with additional contrast agent and patient exposure to radiation (dose-length product [DLP]): 18 ml and 394 mGy*cm in CBCT and 100 ml and 446 mGy*cm in MDCT, respectively.Conclusions
Reduction in perfusion of melanoma metastases after DEBDOX-TACE can be reliably assessed during the intervention via perfusion software at CBCT. Data acquisition and analysis require additional time but can be easily performed during the treatment.Key Points
? Tumour perfusion of melanoma metastases can be assessed at cone beam CT. ? The software shows a significant decrease of tumour perfusion after DEBDOX-TACE. ? Data acquisition and analysis require an acceptable additional time during the procedure. ? CBCT requires less radiation exposure and contrast for perfusion study than MSCT. ? This software can monitor the course of DEBDOX-TACE in melanoma metastases.69.
Ferdinand?SeithEmail authorView authors OrcID profile Andrea?Forschner Holger?Schmidt Christina?Pfannenberg Brigitte?Gückel Konstantin?Nikolaou Christian?la?Fougère Claus?Garbe Nina?Schwenzer 《European journal of nuclear medicine and molecular imaging》2018,45(1):95-101